No Data
No Data
Cantor Fitzgerald Maintains Organogenesis(ORGO.US) With Buy Rating, Maintains Target Price $6
Insider Sale: Director at $ORGO Sells 25,000 Shares
Express News | Organogenesis Shares Are Trading Higher After Morgan Stanley Raised Its Price on the Stock From $4 to $6
Organogenesis Holdings Is Maintained at Equal-Weight by Morgan Stanley
Organogenesis Holdings Analyst Ratings
Morgan Stanley Maintains Organogenesis(ORGO.US) With Hold Rating, Raises Target Price to $6
Magin justin : brother ewwww
玛丽旺旺财 : it's okay bro! It reach 52 weeks high 1.74. Let the trend breathe a while. I also looking for 10 dollars to make everyone richer!
73740385 : i already assume i didnt buy pev